Pancreatic cancer is one of the deadliest cancers worldwide, with a five-year survival rate of 13%. This poor prognosis stems ...

Scientists suggest understanding ecDNA’s role in pancreatic cancer could potentially guide future strategies for making ...

Pancreatic cancer has a notorious capacity to adapt and resist therapy. Now, a study uncovers a hidden driver of this adaptability: extrachromosomal DNA (ecDNA).

Pancreatic cancer is one of the deadliest cancers worldwide, with a five-year survival rate of 13%. This poor prognosis stems from both late detection ...

Pancreatic cancer is one of the deadliest cancers worldwide, with a five-year survival rate of 13%. This poor prognosis stems ...

A new study led by UCLA investigators suggests that chronic stress and an unhealthy diet may work together to fuel the early ...

Pancreatic neuroendocrine cancers are rare cancers. They start in the neuroendocrine cells of the pancreas. Your healthcare team might call them pancreatic neuroendocrine neoplasms, or pancreatic NENs ...

There are two main types of pancreatic cancers—those that start in the exocrine gland and those that start in the endocrine cells. Pancreatic cancer is a rare, but deadly disease. Treatment options ...

Osaka University researchers said Wednesday that they have developed a method to test for pancreatic cancer with pancreatic cells or DNA collected through a modified catheter during gastric ...

Pancreatic NETs grow in your pancreas, a gland in your belly that has two big jobs. It makes juices to digest food, and it makes hormones, which are chemicals that control different actions in ...